New diabetes clinical trial: Freestyle Libre and Hospital Admissions in Type 2 Diabetes | | |
New diabetes clinical trial: Impact of Obesity, Chronic Kidney Disease and Type 2 Diabetes on Human Urinary Stem Cells | | |
New diabetes clinical trial: The Effectiveness of Using a Mobile Application for Type 2 Diabetes Self-care | | |
New diabetes clinical trial: A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients On Metformin Treatmentmet | | |
New diabetes clinical trial: Characteristics of NAFLD Among Type 2 Diabetes Patients | | |
New diabetes clinical trial: Establishment and Preliminary Evaluation of Digital Three Level Linkage Whole Process Diabetes Management System | | |
New diabetes clinical trial: Zinc Supplementation Improves Cardiovascular Morbidity in Patients With Diabetes Mellitus | | |
New diabetes clinical trial: Integrating Abbott Point-of-Care Technologies and the Community Scientist Model to Support HbA1c Testing Per ADA | | |
New diabetes clinical trial: Telemedicine-Delivered Cognitive Behavioral Therapy to Reduce Diabetes Distress | | |
New diabetes clinical trial: A Clinical Efficacy and Safety Study of Insulin Glargine U300 in Chinese Adult Patients With Uncontrolled Type 2 Diabetes Mellitus With a 3-month Extension Period | | |
New diabetes clinical trial: Digitalized Management Exploration for Gestational Diabetes Mellitus in China | | |
New diabetes clinical trial: CSII Versus MDI in Pregnant Women With Type 2 Diabetes | | |
New diabetes clinical trial: Exercise Intervention Combined With Metformin in the Treatment of Type 2 Diabetes | | |
New diabetes clinical trial: The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity. | | Published on: August 13, 2021 at 07:00PM Conditions: Diabetes Mellitus, Type 2; Overweight or Obesity Interventions: Drug: Beinaglutide; Drug: Dulaglutide Sponsors: Second Xiangya Hospital of Central South University; Guangdong Provincial People's Hospital; First Affiliated Hospital of Harbin Medical University; The First Affiliated Hospital of Henan University of Science and Technology Recruiting https://clinicaltrials.gov/ct2/show/NCT05005741?term=diabetes&sfpd_d=14 August 13, 2021 at 03:22PM via ClinicalTrials.gov |
New diabetes clinical trial: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes | | |
New diabetes clinical trial: A Study to Learn More About Chronic Kidney Disease (CKD) in Patients With Type 2 Diabetes Mellitus (T2DM) | | |
Няма коментари:
Публикуване на коментар